Rakesh Pandit Dhavale

Rakesh Pandit Dhavale

Auto-generated profile, based on publicly available information

Rakesh Pandit Dhavale

Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, India

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2023 in Natural Product Research
Verified
Journal Article
Closed access
SRSneha Rochlani
Sneha Rochlani
MBManish Bhatia
Manish Bhatia
SRSanket Rathod
Sanket Rathod
PCPrafulla Choudhari
Prafulla Choudhari
RDRakesh Dhavale
Rakesh Dhavale
Limonoids serve as vital secondary metabolites. Citrus limonoids show a wide range of pharmacological potential. As a result of which limonoids from citrus are of considerable research interest. Identification of new therapeutic molecules from natural origins has been widely adopted as a successful strategy in drug discovery. This work mainly focused on the high-throughput computational exploration of the antiviral potential of three vital limonoids, i.e. Obacunone, Limonin and Nomilin against spike proteins of SARS CoV-2 (PDB:6LZG), Zika virus NS3 helicase (PDB:5JMT), Serotype 2 RNA dependent RNA polymerase of dengue virus (PDB:5K5M). Herein we report the molecular docking, MD simulation studies of nine docked complexes, and density functional theory (DFT) of selected limonoids. The results of this study indicated that all three limonoids have good molecular features but out of these three obacunone exerted satisfactory results for DFT, docking and MD simulation study. Graphical Abstract

27 March 2023 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
SRSanket Rathod
Sanket Rathod
PCPooja Chavan
Pooja Chavan
DMDeepak Mahuli
Deepak Mahuli
SRSneha Rochlani
Sneha Rochlani
SSShalini Shinde
Shalini Shinde
FTFiroj A. Tamboli
Firoj A. Tamboli

20 June 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SRSanket Rathod
Sanket Rathod
SDSreenath Dey
Sreenath Dey
SPSwaranjali Pawar
Swaranjali Pawar
RDRakesh Dhavale
Rakesh Dhavale
PCPrafulla Choudhari
Prafulla Choudhari
HMHarinath More
Harinath More
The cases of bacterial multidrug resistance are increasing every year and becoming a serious concern for human health. Multidrug efflux pumps are key players in the formation of antibiotic resistance, which transfer out a broad spectrum of drugs from the cell and convey resistance to the host. Efflux pumps have significantly reduced the efficacy of the previously available antibiotic armory, thereby increasing the frequency of therapeutic failures. In gram-negative bacteria, the AcrAB-TolC efflux pump is the principal transporter of the substrate and plays a major role in the formation of antibiotic resistance. In the current work, advanced computer-aided drug discovery approaches were utilized to find hit molecules from the library of biogenic chalcones against the bacterial AcrB efflux pump. The results of the performed computational studies via molecular docking, drug-likeness prediction, pharmacokinetic profiling, pharmacophore mapping, density functional theory, and molecular dynamics simulation study provided ZINC000004695648, ZINC000014762506, ZINC000014762510, ZINC000095099506, and ZINC000085510993 as stable hit molecules against the AcrB efflux pumps. Identified hits could successfully act against AcrB efflux pumps after optimization as lead molecules.Communicated by Ramaswamy H. Sarma.
1

1 October 2021 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
RDRakesh P. Dhavale
Rakesh P. Dhavale
SNSameer Nadaf
Sameer Nadaf
MBManish S. Bhatia
Manish S. Bhatia

11 August 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
SDSreenath Dey
Sreenath Dey
SRSanket Rathod
Sanket Rathod
KGKondba Gumphalwad
Kondba Gumphalwad
NYNikhil Yadav
Nikhil Yadav
PCPrafulla Choudhari
Prafulla Choudhari
DMDeepak Mahuli
Deepak Mahuli
Antibiotic resistance has become a pressing global health crisis, with bacterial infections increasingly difficult to treat due to the emergence of multidrug resistance. This study aims to identify potential chalcone molecules that interact with two key multidrug efflux pumps, AcrB and EmrD, of Escherichia coli, using advanced computational tools. In silico ADMET (absorption, distribution, metabolism, excretion, and toxicity), drug-likeness prediction, molecular docking, and molecular dynamics simulation analyses were conducted on a ligand library comprising 100 chalcone compounds against AcrB (PDB: 4DX5) and EmrD (PDB: 2GFP). The results demonstrated that Elastichalcone A (PubChem CID 102103730) exhibited a remarkable binding affinity of -9.9 kcal/mol against AcrB, while 4'-methoxy-4-hydroxychalcone (PubChem CID 5927890) displayed a binding affinity of -9.8 kcal/mol against EmrD. Both ligands satisfied drug-likeness rules and possessed favorable pharmacokinetic profiles. Molecular dynamics simulation of the AcrB-Elastichalcone A complex remained stable over 100 ns, with minimal fluctuations in root-mean-square deviation and root-mean-square fluctuation. The screened ligand library demonstrated good drug-likeness and pharmacokinetic properties. Moreover, the MM/PB(GB)SA calculation indicated the tight binding and thermodynamic stability of the simulated protein-ligand complexes. Overall, this study highlights the potential of chalcones as promising candidates for targeting multidrug efflux pumps, offering a potential strategy to overcome antibiotic resistance. Further exploration and optimization of these compounds may lead to the development of effective therapeutics against multidrug-resistant bacterial infections.Communicated by Ramaswamy H. Sarma.